MannKind (MNKD) Stock Forecast & Price Target

Compare

1,878 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

MNKD Analyst Ratings

Strong Buy

7 Buy

1 Hold

0 Sell

Based on 8 analysts giving stock ratings to

MannKind

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

MNKD Stock 12 Month Forecast

Average Price Target

$8.56

▲(131.35% Upside)

Based on 8 Wall Street analysts offering 12 month price targets for MannKind in the last 3 months. The average price target is $8.56 with a high forecast of $12.00 and a low forecast of $3.50. The average price target represents a 131.35% change from the last price of $3.70.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"$2","13":"$13","4.75":"$4.75","7.5":"$7.5","10.25":"$10.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":12,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$12.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":8.56,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$8.56</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$3.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2,4.75,7.5,10.25,13],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.75,4.384615384615385,5.019230769230769,5.653846153846153,6.288461538461538,6.923076923076923,7.5576923076923075,8.192307692307692,8.826923076923077,9.461538461538462,10.096153846153847,10.73076923076923,11.365384615384615,{"y":12,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.75,4.12,4.49,4.86,5.23,5.6000000000000005,5.970000000000001,6.34,6.710000000000001,7.08,7.450000000000001,7.82,8.190000000000001,{"y":8.56,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.75,3.730769230769231,3.7115384615384617,3.6923076923076925,3.673076923076923,3.6538461538461537,3.6346153846153846,3.6153846153846154,3.5961538461538463,3.576923076923077,3.5576923076923075,3.5384615384615383,3.519230769230769,{"y":3.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":5.55,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.26,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.26,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.17,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.59,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.43,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.79,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.34,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.95,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.95,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.29,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.58,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.75,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$12.00

Average Price Target$8.56

Lowest Price Target$3.50

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Steven Lichtman

Oppenheimer

$8→$12

Buy

224.32%

Upside

Reiterated

08/07/25

Oppenheimer Sticks to Its Buy Rating for MannKind (MNKD)

Anthony Petrone

Mizuho Securities

$12→$10

Buy

170.27%

Upside

Reiterated

08/07/25

Mizuho Securities Remains a Buy on MannKind (MNKD)

Douglas Miehm

RBC Capital

$8→$7

Buy

89.19%

Upside

Reiterated

08/07/25

RBC Capital Remains a Buy on MannKind (MNKD)

Dex Genotek

TR | OpenAI - 4o

$4→$3.5

Hold

-5.41%

Downside

Reiterated

08/07/25

AI Generated ArticleAI Generated Article

Faisal Khurshid

Leerink Partners

Buy

89.19%

Upside

Reiterated

08/06/25

MannKind's Growth Potential and Stability: Buy Rating Reinforced by Pipeline Progress and Strategic Catalysts

Brandon Folkes

H.C. Wainwright

Buy

143.24%

Upside

Reiterated

08/06/25

MannKind's Strategic Growth Potential and Undervalued Stock: A Buy Rating Amid Market Overreactions

Yun Zhong

Wedbush

$11

Buy

197.30%

Upside

Reiterated

08/06/25

Promising Outlook for MannKind: Buy Rating Justified by Clinical Progress and Financial Strength

Tiago Fauth

Wells Fargo

$13→$9

Buy

143.24%

Upside

Reiterated

06/10/25

Analysts Offer Insights on Healthcare Companies: Amgen (NASDAQ: AMGN), Humana (NYSE: HUM) and MannKind (NASDAQ: MNKD)

Olivia Brayer

Cantor Fitzgerald

Buy

143.24%

Upside

Reiterated

03/20/25

MannKind (MNKD) Gets a Buy from Cantor Fitzgerald

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Steven Lichtman

Oppenheimer

$8→$12

Buy

224.32%

Upside

Reiterated

08/07/25

Oppenheimer Sticks to Its Buy Rating for MannKind (MNKD)

Anthony Petrone

Mizuho Securities

$12→$10

Buy

170.27%

Upside

Reiterated

08/07/25

Mizuho Securities Remains a Buy on MannKind (MNKD)

Douglas Miehm

RBC Capital

$8→$7

Buy

89.19%

Upside

Reiterated

08/07/25

RBC Capital Remains a Buy on MannKind (MNKD)

Dex Genotek

TR | OpenAI - 4o

$4→$3.5

Hold

-5.41%

Downside

Reiterated

08/07/25

AI Generated ArticleAI Generated Article

Faisal Khurshid

Leerink Partners

Buy

89.19%

Upside

Reiterated

08/06/25

MannKind's Growth Potential and Stability: Buy Rating Reinforced by Pipeline Progress and Strategic Catalysts

Brandon Folkes

H.C. Wainwright

Buy

143.24%

Upside

Reiterated

08/06/25

MannKind's Strategic Growth Potential and Undervalued Stock: A Buy Rating Amid Market Overreactions

Yun Zhong

Wedbush

$11

Buy

197.30%

Upside

Reiterated

08/06/25

Promising Outlook for MannKind: Buy Rating Justified by Clinical Progress and Financial Strength

Tiago Fauth

Wells Fargo

$13→$9

Buy

143.24%

Upside

Reiterated

06/10/25

Analysts Offer Insights on Healthcare Companies: Amgen (NASDAQ: AMGN), Humana (NYSE: HUM) and MannKind (NASDAQ: MNKD)

Olivia Brayer

Cantor Fitzgerald

Buy

143.24%

Upside

Reiterated

03/20/25

MannKind (MNKD) Gets a Buy from Cantor Fitzgerald

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering MannKind

1 Month

xxx

Success Rate

12/18 ratings generated profit

Average Return

+5.52%

reiterated a xxx

rating 9 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +5.52% per trade.

3 Months

xxx

Success Rate

13/18 ratings generated profit

Average Return

+20.11%

reiterated a xxx

rating 9 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 72.22% of your transactions generating a profit, with an average return of +20.11% per trade.

1 Year

Steven LichtmanOppenheimer

Success Rate

13/18 ratings generated profit

Average Return

+73.87%

reiterated a buy rating 9 days ago

Copying Steven Lichtman's trades and holding each position for 1 Year would result in 72.22% of your transactions generating a profit, with an average return of +73.87% per trade.

2 Years

xxx

Success Rate

14/18 ratings generated profit

Average Return

+53.46%

reiterated a xxx

rating 9 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 77.78% of your transactions generating a profit, with an average return of +53.46% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MNKD Analyst Recommendation Trends

Rating

Apr 25

May 25

Jun 25

Jul 25

Aug 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, MNKD has received 15 Buy Ratings, 8 Hold Ratings, and 0 Sell Ratings. MNKD average Analyst price target in the past 3 months is 8.56.

Each month's total comprises the sum of three months' worth of ratings.

MNKD Financial Forecast

MNKD Earnings Forecast

Next quarter’s earnings estimate for MNKD is $0.02 with a range of $0.01 to $0.04. The previous quarter’s EPS was $0.00. MNKD beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.31% of the time in the same period. In the last calendar year MNKD has Outperformed its overall industry.

MNKD Sales Forecast

Next quarter’s sales forecast for MNKD is $80.38M with a range of $78.00M to $85.27M. The previous quarter’s sales results were $76.53M. MNKD beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 47.54% of the time in the same period. In the last calendar year MNKD has Outperformed its overall industry.

MNKD Stock Forecast FAQ

What is MNKD’s average 12-month price target, according to analysts?

Based on analyst ratings, Mannkind Corp.’s 12-month average price target is 8.56.

What is MNKD’s upside potential, based on the analysts’ average price target?

Mannkind Corp. has 131.35% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is MNKD a Buy, Sell or Hold?

Mannkind Corp. has a consensus rating of Strong Buy which is based on 7 buy ratings, 1 hold ratings and 0 sell ratings.

What is Mannkind Corp.’s price target?

The average price target for Mannkind Corp. is 8.56. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $12.00 ,the lowest forecast is $3.50. The average price target represents 131.35% Increase from the current price of $3.7.

What do analysts say about Mannkind Corp.?

Mannkind Corp.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Streets Analysts.

How can I buy shares of MNKD?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

MannKind (MNKD) Stock Forecast & Price Target

MNKD Analyst Ratings

MNKD Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering MannKind

MNKD Analyst Recommendation Trends

MNKD Financial Forecast

MNKD Earnings Forecast

MNKD Sales Forecast

MNKD Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts